A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors

NCT04615312 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Digestive System Tumors

Interventions

DRUG: a CDK4 / 6 inhibitor and a MEK inhibitor

Sponsor

Henan Cancer Hospital